Jun 26, 2023
A protocol of application of medicament testing method based on the electrodermal measurement of acupuncture points in diagnosis of SARS-CoV-2 infection
- naila.djumaeva 1
- 1Scientific Research Institute of Virology at the National Specialized Scientific and Practical Medical Center for Epidemiology, Microbiology, Infectious and Parasitic Diseases, Uzbekistan
Protocol Citation: naila.djumaeva 2023. A protocol of application of medicament testing method based on the electrodermal measurement of acupuncture points in diagnosis of SARS-CoV-2 infection. protocols.io https://dx.doi.org/10.17504/protocols.io.6qpvr3e3zvmk/v1
License: This is an open access protocol distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Protocol status: Working
We use this protocol and it's working
Created: June 20, 2023
Last Modified: June 26, 2023
Protocol Integer ID: 83682
Keywords: Voll electroacupuncture diagnostic device, SARS-CoV-2, acupuncture points, electrodermal measurement of acupuncture point, acupuncture point, medicament testing method, diagnosis of sar, electrodermal measurement, infection this protocol details application, infection, diagnosis
Abstract
This protocol details application of medicament testing method based on the electrodermal measurement of acupuncture points in diagnosis of SARS-CoV-2 infection.
Attachments
745-1896.pdf
87KB
Application of medicament testing method
Medication testing is carried out with a Voll electroacupuncture diagnostic device (EAV) equipped with software containing information about nosodes (homeopathic preparations consisting of potentiated antigens and their components of various viruses, bacteria, fungi and other infectious agents).
To diagnose SARS-CoV-2 by medicament testing, the following markers of the disease are used: the nosode of RNA polymerase, antiviral drug ribavirin (200 mg, tablets), and dexamethasone (0.5 mg, tablets).
The EAV diagnostic device contains the core apparatus with an external test honeycomb (for medicament testing), the point probe, metallic hand electrodes and a computer equipped with a software system. During an EAV diagnostic, a patient holds the metallic hand electrode, which is connected by a wire to the EAB device. At the same time, an expert in Voll diagnosis completes the electrical circuit by pressing on the patient’s acupuncture points of interest with the point probe.
Display acupuncture point measurement in analogue as a light bar on the light bar display. Assess the functional status according to Voll's recommendations, when the electrical current of the AP and the device are identical in interaction, which corresponds to 50-70 units of the device display scale, which is considered to be the so-called energy balance or a healthy state of the examined organ. Changes in the readings of the device indicate certain processes occurring in the organ under study, functionally related to the acupuncture point on which the measurement is performed.
The second feature is to record the phenomenon of indicator drop, where once the maximum values on the instrument display are reached, the instrument indicator moves back towards zero. If the acupuncture point under study shows a drop in the indicator, place the drug into the honeycomb or plug the nosode in question into the apparatus-patient circuit using the HOMOPATH software system containing information about virus or its components.
Assess the response of the device’s indicator according to the recommendations of Voll diagnostics. A positive acupuncture point response to the drug or nosode being tested indicates the presence of a substance in the organ being tested that is close to or identical in structure to the object being tested.
To diagnose SARS-CoV-2 by medicament testing, it is proposed to use for the diagnosis SARS-Cov-2 the following markers of the disease: the nosode of RNA polymerase (The EAV Homopath software), antiviral drug Ribavirin (200 mg, tablets), and Dexematosone (0.5 mg, tablets). These drugs are administered sequentially one after another - first, the nosode for which the EAV Homopath program is connected, and then the drugs Ribavirin and Dexamethasone are connected to the circuit: the patient and EAV device.
The positive response to the RNA polymerase nosode in the medicament testing process indicates that there is an identical biological substance in the organ or tissue under study. A positive response to Ribavirin testing in the medicament testing process indicates the presence of an RNA-containing virus in the organ or tissue of the body under study, the replication of which occurs with the participation of viral polymerase. The positive response to Dexamethasone during the medicament testing process confirms the existing inflammatory process in the studied body tissue. In general, a positive response to testing all three drugs during MT, when they are placed sequentially one after another, in the honeycomb of the electropuncture diagnostic device (nosode of RNA polymerase, Ribavirin and Dexamethasone), suggests the presence of RNA-containing virus replication which is associated with RNA polymerase that causes an inflammatory process in the organ or tissue studied by the medicament testing method.